Technical Analysis for SGIOY - Shionogi & Co Ltd Un

Grade Last Price % Change Price Change
grade C 13.43 -1.10% -0.1500
SGIOY closed down 1.1 percent on Thursday, August 22, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical SGIOY trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
20 DMA Resistance Bearish -1.10%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.10%
Pocket Pivot Bullish Swing Setup -1.10%
Outside Day Range Expansion -1.10%
Up 3 Days in a Row Strength -1.10%
Up 4 Days in a Row Strength -1.10%
20 DMA Resistance Bearish -1.07%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.07%
Narrow Range Bar Range Contraction -1.07%

Older signals for SGIOY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company primarily focuses on metabolic syndrome, pain, infectious diseases, cholesterol medication, anti-hypertension drugs, depression treatment, prescription drugs, OTC drugs, and diagnostics. Its primary products include Cymbalta, a serotonin and noradrenaline reuptake inhibitor used for the treatment of depression, anxiety, diabetic neuropathic pain, fibromyalgia pain, chronic lower back pain, and osteoarthritis pain; Intuniv, a selective a2 adrenergic receptor agonist to treat attention-deficit hyperactivity disorder; Xofluza, an anti-influenza agent; and Symproic, a cancer pain analgesic tablet. It has a research collaborative agreement with National University Corporation Kyoto University to focus on drug discovery and medical research for the treatment of psychiatric disorders; strategic collaboration with Sage Therapeutics, Inc. to develop and commercialize SAGE-217 for MDD and other indications; license and research collaboration for the treatment of mycobacterial diseases with Hsiri Therapeutics Inc.; a strategic collaboration with Tetra Discovery Partners LLC for the clinical development and commercialization of BPN14770, a selective phosphodiesterase-4D allosteric inhibitor; and a collaborative research agreement with PeptiDream Inc. for the discovery and development of a series of blood brain barrier penetrating peptide drug-conjugates. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.
Chemistry RTT Cancer Pharmaceuticals Drugs Pain Infectious Diseases Chemical Compounds Drug Discovery Osteoarthritis Depression Fibromyalgia Psychiatric Disorders Back Pain Metabolic Syndrome Treatment Of Depression Attention Deficit Hyperactivity Disorder Kyoto University Depression Treatment Duloxetine Mycobacterial Diseases Naldemedine National University Corporation Kyoto University Shionogi Symproic Treatment Of Mycobacterial Diseases Treatment Of Psychiatric Disorders
Is SGIOY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 17.1375
52 Week Low 12.27
Average Volume 16,674
200-Day Moving Average 14.8819
50-Day Moving Average 14.0305
20-Day Moving Average 13.5918
10-Day Moving Average 13.4515
Average True Range 0.3622
ADX 10.51
+DI 16.9528
-DI 19.0187
Chandelier Exit (Long, 3 ATRs ) 13.3834
Chandelier Exit (Short, 3 ATRs ) 14.1066
Upper Bollinger Band 14.1184
Lower Bollinger Band 13.0652
Percent B (%b) 0.35
BandWidth 7.74879
MACD Line -0.1688
MACD Signal Line -0.1954
MACD Histogram 0.0265
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.8650
Resistance 3 (R3) 13.8967 13.7833 13.7925
Resistance 2 (R2) 13.7833 13.6726 13.7675 13.7683
Resistance 1 (R1) 13.6067 13.6041 13.5500 13.5750 13.7442
Pivot Point 13.4933 13.4933 13.4650 13.4775 13.4933
Support 1 (S1) 13.3167 13.3826 13.2600 13.2850 13.1158
Support 2 (S2) 13.2033 13.3141 13.1875 13.0917
Support 3 (S3) 13.0267 13.2033 13.0675
Support 4 (S4) 12.9950